SummaryEli Lilly will hike UK prices of diabetes and weight-loss drug Mounjaro by up to 170% from September, affecting private patients but not the NHS. Mounjaro aids blood sugar control and weight loss, but cost increases may force many to reconsider long-term treatment despite its significant health benefits and convenience.